Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2015
|
| In: |
American heart journal
Year: 2015, Volume: 170, Issue: 4, Pages: 675-682.e8 |
| ISSN: | 1097-6744 |
| Online Access: | Verlag, kostenfrei, Volltext: http://www.sciencedirect.com/science/article/pii/S0002870315004433
|
| Author Notes: | Sameer Bansilal, Zachary Bloomgarden, Jonathan L. Halperin, Anne S. Hellkamp, Yuliya Lokhnygina, Manesh R. Patel, Richard C. Becker, Günter Breithardt, Werner Hacke, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Scott D.Berkowitz, Jonathan P. Piccini, Kenneth W. Mahaffey, and Keith A. A. Fox |
| Item Description: | Gesehen am 22.09.2015 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1097-6744 |